Literature DB >> 15274117

Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.

Pierre Lescuyer1, Laure Allard, Catherine G Zimmermann-Ivol, Jennifer A Burgess, Séverine Hughes-Frutiger, Pierre R Burkhard, Jean-Charles Sanchez, Denis F Hochstrasser.   

Abstract

Only few biological markers are currently available for the routine diagnosis of brain damage-related disorders including cerebrovascular, dementia, and other neurodegenerative diseases. In this study, post-mortem cerebrospinal fluid samples were used as a model of massive brain insult to identify new markers potentially relevant for neurodegeneration. The protein pattern of this sample was compared to the one of cerebrospinal fluid from healthy subjects by two-dimensional gel electrophoresis. Using gel imaging, N-terminal microsequencing, mass spectrometry, and immunodetection techniques, we identified 13 differentially expressed proteins. Most of these proteins have been previously reported to be somehow associated with brain destruction or with the molecular mechanisms underlying certain neurodegenerative conditions. These data indicate that the identified proteins indeed represent potential biomarkers of brain damage. We recently showed that H-FABP, a protein highly homologous to E-FABP and A-FABP identified in this study, is a potential marker of Creutzfeldt-Jakob disease and stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274117     DOI: 10.1002/pmic.200300822

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  29 in total

1.  Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.

Authors:  Srikanth Ranganathan; Georgina C B Nicholl; Sarah Henry; Fran Lutka; Ramasri Sathanoori; David Lacomis; Robert Bowser
Journal:  Amyotroph Lateral Scler       Date:  2007-08-03

Review 2.  Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Authors:  Leila H Choe; Brenda G Werner; Kelvin H Lee
Journal:  NeuroRx       Date:  2006-07

3.  Proteomic-Based Approaches for the Study of Ischemic Stroke.

Authors:  Haiying Li; Wanchun You; Xiang Li; Haitao Shen; Gang Chen
Journal:  Transl Stroke Res       Date:  2019-07-05       Impact factor: 6.829

Review 4.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

5.  Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke.

Authors:  Poyin Huang; Li-Hua Lo; Yin-Chun Chen; Ruey-Tay Lin; Jentaie Shiea; Ching-Kuan Liu
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

6.  Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke.

Authors:  Laure Allard; Natacha Turck; Pierre R Burkhard; Nadia Walter; Anna Rosell; Marianne Gex-Fabry; Denis F Hochstrasser; Joan Montaner; Jean-Charles Sanchez
Journal:  Biomark Insights       Date:  2007-04-19

7.  A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage.

Authors:  Natacha Turck; Laszlo Vutskits; Paola Sanchez-Pena; Xavier Robin; Alexandre Hainard; Marianne Gex-Fabry; Catherine Fouda; Hadiji Bassem; Markus Mueller; Frédérique Lisacek; Louis Puybasset; Jean-Charles Sanchez
Journal:  Intensive Care Med       Date:  2009-09-17       Impact factor: 17.440

8.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

9.  The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.

Authors:  Jin-Moo Lee; Kaj Blennow; Niels Andreasen; Omar Laterza; Vijay Modur; Jitka Olander; Feng Gao; Matt Ohlendorf; Jack H Ladenson
Journal:  Clin Chem       Date:  2008-08-14       Impact factor: 8.327

10.  A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.

Authors:  Alexandre Hainard; Natalia Tiberti; Xavier Robin; Veerle Lejon; Dieudonné Mumba Ngoyi; Enock Matovu; John Charles Enyaru; Catherine Fouda; Joseph Mathu Ndung'u; Frédérique Lisacek; Markus Müller; Natacha Turck; Jean-Charles Sanchez
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.